| Literature DB >> 27918471 |
Amaya Azqueta1,2, Andrew Collins3.
Abstract
Polyphenols are a very broad group of chemicals, widely distributed in plant foods, and endowed with antioxidant activity by virtue of their numerous phenol groups. They are widely studied as putative cancer-protective agents, potentially contributing to the cancer preventive properties of fruits and vegetables. We review recent publications relating to human trials, animal experiments and cell culture, grouping them according to whether polyphenols are investigated in whole foods and drinks, in plant extracts, or as individual compounds. A variety of assays are in use to study genetic damage endpoints. Human trials, of which there are rather few, tend to show decreases in endogenous DNA damage and protection against DNA damage induced ex vivo in blood cells. Most animal experiments have investigated the effects of polyphenols (often at high doses) in combination with known DNA-damaging agents, and generally they show protection. High concentrations can themselves induce DNA damage, as demonstrated in numerous cell culture experiments; low concentrations, on the other hand, tend to decrease DNA damage.Entities:
Keywords: DNA damage; DNA protection; flavonoids; human studies; in vitro; in vivo; polyphenols
Mesh:
Substances:
Year: 2016 PMID: 27918471 PMCID: PMC5188440 DOI: 10.3390/nu8120785
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Effects of whole foods or drinks on various genetic damage endpoints, in humans, in animals (‘in vivo’), and in cultured cells (‘in vitro’).
| Reference | Material Tested | Analysis | Assays | System | Concentration/Dose | Result |
|---|---|---|---|---|---|---|
| [ | Orange juice | Polyphenols | 8-OH–G in urine by ELISA | Overweight/obese humans | 300 or 745 mg/day (12 weeks) | 8-OH–G ↓ |
| [ | Aronia-citrus juice | Flavonones, flavones, antocyanins etc. | 8-OH–G in plasma by UHPLC-MS/MS | Triathletes (supplemented and placebo groups) | 200 mL/day (45 days) | Inconclusive—levels of DNA damage products too low |
| [ | Dark chocolate | Polyphenols | Comet assay | Healthy subjects: PBMN cells | 860 mg/day (2 weeks) | H2O2-induced SBs ↓ (short-term—2 h—only) |
| [ | De-alcoholised wine | Anthocyanins, flavonols etc. | Comet assay with Fpg | Post-menopausal women; peripheral blood lymphocytes | 500 mL/day (1 month) | No effect |
| [ | Wild blueberry drink | Phenolic acids and anthocyanins | Comet assay + Fpg; H2O2resistance (comet assay); DNA repair (in vitro comet assay) | Subjects with cardiovascular risk factors: PBMN cells | 375 mg anthocyanins/day (6 weeks) | No effect on DNA SBs. Fpg-sensitive sites ↓; H2O2 resistance ↑; no effect on repair |
| [ | Green tea | Comet assay | Healthy subjects: PBMN cells 30, 60, 90 min after ingestion, exposed ex vivo to UV(A)/VIS radiation | Single 540 mL dose | Protection against UV(A)/VIS-induced DNA SBs seen in ‘responders’ | |
| [ | Honey | Phenolic compounds | Comet assay with EndoIII, Fpg | Pesticide-exposed humans | 2-week honey supplementation (50 g/day) | DNA repair ↑, EndoIII and Fpg sites ↓ |
| [ | Polyphenols, Mg, Se | Comet assay on blood and MN assay on bone marrow and PBMN | Rats + Dox | Up to 0.4 g/kg/day for 14 days | Blood cells; DNA SBs ↓. Bone marrow, blood cells; MN ↓ | |
| [ | Green and black teas | 8-OH–G on liver by HPLC | Swiss albino mice + Na arsenite | 2.5% of 0.5 g dry leaves/5 mL of boiled water (equivalent to human consumption of 1 cup). 22 days. | Protection (8-OH–G ↓) | |
| [ | Piquia pulp | Phenolic compounds, carotenoids | Comet assay on liver, kidney, heart cells MN on bone marrow and PBMN cells | Rats + Dox | 75, 150, 300 mg/kg/day for 14 days | Protection against DNA SBs and MN formation: lowest dose tends to be most effective |
| [ | Açai pulp | Phenolic compounds, carotenoids | Comet assay on liver, kidney and PBMN cells: MN on bone marrow and PBMN cells | Mice + Dox | 3.33,10, 16.7 g/kg/day for 1 or 14 days | Protection against DNA SBs and MN formation: 14 days pretreatment more effective |
| [ | Cloudy apple juice | Polyphenols | Comet assay on liver cells | Rats | 10 mL/kg/day for 28 days | DNA SBs ↑ and no effect on N-nitrosodiethylamine-induced damage |
| [ | Green tea | -- | Comet assay on intestinal cells | Rats + As | 10 mg/mL in water for 28 days | Claim protection |
| [ | Spinach | Total polyphenols | Comet assay on leukocytes | Hyperlipidemic rats | 5% (powder) in diet, for 6 weeks | H2O2-induced DNA SBs in leukocytes ↓ |
| [ | Green tea | -- | Comet assay with Fpg | Human PBMN cells | 7–71 µM catechins | DNA damage ↓ at lower concentrations but ↑ at highest concentration |
| [ | Herbal preparation | Total phenolics | Comet assay | YAC-1 (mouse lymphoma) cells | 1–13 mg/mL | DNA SBs ↑ at 8.7 mg/mL |
| Rat fibroblasts | 1–13 mg/mL | DNA SBs ↑ at 2.2 mg/mL | ||||
| [ | Various honeys | -- | Comet assay | HepG2 (human liver carcinoma) cells treated with B(a)P, PhIP, nitrosamines | 0.1–100 mg/mL | Slight decreases in DNA SBs in most cases, not dose-dependent |
PBMN: peripheral blood mononuclear; SB: strand break; Fpg: formamidopyrimidine DNA glycosylase; UV: ultraviolet; VIS: visible; MN: micronucleus/micronuclei; Dox: doxorubicin; EndoIII: endonuclease III (Nth); 8-OH–G: 8-oxo–7,8-dihydroguanine; B(a)P: benzo(a)pyrene; PhIP: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Effects of plant extracts on various genetic damage endpoints, in humans, in animals (‘in vivo’), and in cultured cells (‘in vitro’).
| Reference | Material tested | Analysis | Assays | System | Concentration/Dose | Result |
|---|---|---|---|---|---|---|
| [ | Green tea polyphenols | Urinary 8-OH–G by HPLC | Postmenopausal women with osteoporosis | 500 mg/day (capsules, 6 months) | 8-OH–G ↓ over 6 months | |
| [ | Green tea polyphenols | 8-OH–G in brain by Ab assay | Rats | 400 mg/day (gastric intubation, 4 weeks) | 8-OH–G ↓ | |
| [ | Green tea polyphenols | Epicatechin derivatives | CPD on skin and lymph nodes by Ab assay | Mice (NER+ and-) + UV | 0.2% in drinking water (7 days before UV irradiation) | Enhanced removal of CPDs in NER-proficient mice |
| [ | Green tea extract | MN in polychromatic erythrocytes | Mice + Cr(VI) | 30 mg/kg (one dose—gavage) | MN ↓ | |
| [ | Green tea polyphenols | Comet assay with Fpg on blood; 8-OH–G in brain by HPLC | Rats + acrylonitrile | 0.4% in diet (1 week before acrylonitrile and then throughout acrylonitrile treatment for 28 days) | ↓ Fpg-sensitive sites and 8-OH–G ↓ | |
| [ | CPDs in skin by Ab assay | Mice + UV(B) | 4 mg/cm2 (30 min before exposure to UV, repeated on 10 days) | CPDs ↓ | ||
| [ | Total phenolics | Alkaline halo assay; DNA repair (SB rejoining—PCR assay) | Thymocytes from γ-irradiated mice | 15 mg/kg (one dose, i.p.) | Protection against γ-ray-induced DNA SBs and accelerated rejoining | |
| [ | Comet assay on liver | Rats + pyrogallol | 0.5–2 g/kg (single dose, i.p.) | SBs at highest dose of extract alone: protection against pyrogallol-induced SBs at 0.5 g/kg | ||
| [ | Green tea polyphenols | Comet assay | Melanoma cell lines | 20–60 μg/mL (time) | 40, 60 μg/mL; DNA SBs ↑ | |
| [ | Green tea extract | Comet assay | Human laryngeal carcinoma cell line (HEp2) + drug-resistant cell line CK2 | 1× = 2 g/200 mL H2O2 Concentration tested = 0.1× | SBs ↑ at 72 h, not 48 h | |
| [ | Citrus and rosemary bioflavonoid extract | Total polyphenols | Comet assay | HaCaT (human keratinocytes) + UV(B) | 100 μg/mL | Pre-treatment: UV(B)-induced DNA SBs ↓ |
| MN | Human lymphocytes + X-ray | 1 mg/mL | X-ray induced MN ↓ | |||
| [ | Comet assay and γ-H2AX by Ab | Human skin model exposed to UV(B) | 1.8 μg/mL | Protection against DNA damage | ||
| [ | Comet assay 24 h after UV | NCTC (human keratinocytes) + UV(A) or UV(B) | 1.82 μg/mL | DNA SBs ↓ | ||
| MN | No effect seen | |||||
| γ-H2AX by Ab | No effect seen | |||||
| [ | Lemon balm extract | Polyphenols | Comet assay and γ-H2AX by Ab assay | Human keratinocytes + UV(B) | 15–100 μg/mL | DNA SBs ↓ (100 μg/mL); γH2AX ↓ (15 μg/mL) |
| [ | Total phenolics | Comet assay | SH-SY5Y (human neuroblastoma) cells | 75 μg/mL | H2O2-induced DNA SBs ↓ | |
| [ | Various | Total polyphenols, flavonoids | Comet assay | HepG2 (human liver carcinoma) cells + CdCl2 | 50–350 μg/mL for 4 h | Dose-dependent decrease in Cd-induced DNA SBs |
| [ | Strawberry extract | Anthocyanins | Comet assay | Human dermal fibroblasts exposed to UV(A) | 0.05–0.5 mg/mL | Protection against DNA SBs at 0.25, 0.5 mg/mL |
| [ | Strawberry extract | Total phenolics, flavonoids, anthocyanins, vitamin C, β-carotene | Comet assay | Human dermal fibroblasts exposed to H2O2 | 0.5 mg/mL | DNA SBs ↓ |
| [ | Total polyphenols and anthocyanins | Comet assay | A549 (human lung adenocarcinoma) cells | 21–167 μg/mL | Dose-dependent protection against DNA SBs induced by t-BOOH | |
| [ | Blackcurrant extract | Comet assay (H2O2 resistance) | TK6 (human lymphoblastoid) cells | 0.5–3 mg/mL | H2O2-induced DNA SBs ↓ | |
| MN ± H2O2 | 1 mg/mL | H2O2-induced MN ↓ | ||||
| [ | Various apple polyphenol s extract | Monomeric polyphenols oligosaccharides and oligomeric procyanidins. | Comet assay with Fpg | Caco2 (colon carcinoma) cells | 1–100 μg/mL | Menadione-induced DNA SBs and Fpg-sensitive sites ↓ Greatest protection at low concentrations; with some extracts, damage ↑ at high doses |
| [ | Polyphenol extracts of Australian fruits | Phenolic acids and anthocyanins | MN | HT29 (human colon adenocarcinoma) cells | 0.5–1 mg/mL | MN ↑ with one extract |
| [ | Red wine extract | Comet assay | HUVECs (human umbilical vein endothelial) cells + | 25 μg/mL | DNA SBs ↓ | |
| [ | Honey extract | Phenolic compounds | Comet assay with EndoIII, Fpg | Bronchial epithelial and neuronal cells | 5 μg/mL | Pesticide (glyphosate, chlorpyrifos)-induced damage (SBs, EndoIII and Fpg sites) ↓ |
| Cellular DNA repair | Protection against inhibition of repair of DNA SBs by pesticides | |||||
| [ | Propolis extr | Comet assay | Fibroblasts | 0.1–0.3 mg/mL | γ-Ray-induced DNA SBs ↓ | |
| [ | Propolis | Comet assay + Fpg, EndoIII | Human gastric cancer cell line AGS | 0.3 µg/mL | High DNA damage, suppressed by antioxidants or catalase | |
Ab: antibody; CPD: cyclobutane pyrimidine dimer; NER: nucleotide excision repair; i.p.: intraperitoneal; t-BOOH: tert-butyl hydroperoxide; HUVEC: human umbilical vein endothelial cell.
Effects of individual polyphenolic compounds on various genetic damage endpoints, in humans, in animals (‘in vivo’), and in cultured cells (‘in vitro’).
| Reference | Material Tested | Assays | System | Concentration/Dose | Result |
|---|---|---|---|---|---|
| [ | Epigallocatechin gallate | 8-OH–G in leukocyte DNA (HPLC/UV/MS) | Prostate cancer patients | 800 mg/day (3 to 6 weeks before surgery) | Decrease in 8-OH–G not significant |
| [ | Xanthohumol (drink) | Comet assay and urinary 8-OH–G (UPLC) | Cross over intervention trial, healthy subjects | 12 mg/day for 14 days | FPG-sites ↓, H2O2-induced SBs ↓, 8-OH–G ↓ |
| Xanthohumol (pills) | Comet assay | Parallel intervention trial, healthy subjects | FPG-sites ↓, H2O2-induced SBs ↓ | ||
| [ | Luteolin | Comet assay and MN on blood and bone marrow | Mice + ochratoxin A | 2.5 mg/kg (one dose i.p.) | No effect |
| Chlorogenic acid | 10 mg/kg (one dose i.p.) | DNA SBs ↓; also MN ↓ | |||
| Caffeic acid | 10 mg/kg (one dose i.p.) | DNA SBs ↓ | |||
| [ | Curcumin | Comet assay with FPG on bone marrow | Rats + etoposide | 100 or 200 mg/kg/day (7 days, gavage) | Pretreatment → etoposide-induced DNA damage ↓ |
| Epicatechin | 20 or 40 mg/kg/day (7 days, gavage) | Pretreatment → etoposide-induced oxidative DNA damage ↓ (less than with Curcumin) but not DNA SBs. | |||
| [ | Ellagic acid | MN in polychromatic erythrocytes; alkaline unwinding | Swiss albino mice + cyclophosphamide | 50/100 mg/kg/day (orally, 7 days) | Protection against MN formation and DNA SBs |
| [ | Epigallocatechin gallate and theaflavin | Alkaline unwinding assay | Mouse skin + dimethylbenzanthracene | 100 μg/mouse (topical application, 1 h) | Topical pretreatment → DNA SBs ↓ |
| Epigallocatechin gallate and theaflavin as NPs (PLGA) | 5–20 μg/mouse (topical application, 1 h) | NP form has ~30-fold dose-advantage | |||
| [ | Epigallocatechin gallate | γ-H2AX by Western blot and Ab and 8-OH–G by Ab assay | H1299 (human lung cancer cells) xenografts in mice | 0.1%–0.5% in diet, 30 mg/kg/day injection | Dose-dependent ↑ in γ-H2AX and 8-OH–G |
| [ | Silibinin | 8-OH–G in various brain regions by ELISA | Diabetic mice | 20 mg/kg/day i.p. (4 weeks) | 8-OH–G ↓ in different regions of brain |
| [ | Quercetin | MN in bone marrow and blood | Rats + PCBs | 50 mg/kg/day for 25 days | PCB-induced MN ↓ |
| [ | Quercetin | Chrom abs and MN in bone marrow; Comet assay on blood | Mice + γ-irradiation | 20 mg/kg/day for 5 days | Radiation-induced Chrom abs, SBs, MN ↓ |
| Rutin | 10 mg/kg/day for 5 days | ||||
| [ | Chrysin | Comet assay (hepatocytes and leukocytes) | Rats + methyl mercury | 0.1, 1, 10 mg/kg/day for 45 days | MeHg-induced SBs ↓ at higher doses |
| [ | Puerarin | 8-OH–G in kidney by HPLC | Mice + CCl4 | 0.2 or 0.4 g/kg/day for 4 weeks | 8-OH–G ↓ |
| [ | Quercetin | 8-OH–G in kidney by HPLC | Rats + lead | 10 mg/kg/day for 10 weeks | 8-OH–G ↓ |
| [ | Myricitrin, Myricetin | MN (reticulocytes); Comet assay (liver, duodenum, stomach) | Mice | 1, 1.5, 2 g/kg/day for 3 days | No increase in MN, SBs only in liver + myricetin |
| [ | Quercetin | Comet assay on liver | Rats + DEN | 10, 30, 100 mg/kg/day for 5 days | DEN-induced SBs ↓ |
| [ | Myricetin | Comet assay on liver | Rats + pyrogallol | 255.5 μg/kg 2 h and 12 h before pyrogallol | SBs ↓ in liver |
| [ | Quercitin | Comet assay on liver | Rats + acrylamide | 10 mg/kg/day for 5 days | No effect of quercetin alone. Acrylamide-induced SBs ↓ |
| 8-OH–G in liver by ELISA | No effect of quercetin alone. Acrylamide-induced 8-OH–G ↓ | ||||
| [ | Naringin | Comet assay | Mice (hepatocytes and cardiocytes) | 50, 250 or 500 mg/kg oral (one dose) | No effect |
| 50, 250 or 500 mg/kg oral (one dose) + Dau i.p. | DNA SBs induced by Dau ↓ | ||||
| [ | Apigenin | Chrom abs and MN in bone marrow; comet assay on skin; DNA repair (removal of CPDs by Ab) | Mice + UV(B) | 1.5–3 mg/cm2 (24 h; during UV irradiation) | Chrom abs and MN ↓; tail length ↓. Removal of dimers apparently stimulated by apigenin |
| [ | Chlorogenic acid | Comet assay | HaCaT (human keratinocytes) cells + UV(B) | Not stated. Probably 5–80 μM | DNA SBs ↓ |
| [ | Chlorogenic acid | Comet assay | K562 (human leukaemia) cells | 0.5–5 mM | DNA SBs ↑ |
| γ-H2AX by Ab | Chinese hamster AA8 cell line and K562 | 0.5 mM | γ-H2AX foci ↑ | ||
| [ | Chafuroside B (tea polyphenol) | CPDs by Ab | Human keratinocytes + UV(B) | 1 μM | CPDs ↓ after 24 h |
| [ | Ellagic acid | Comet assay | Prostate cancer cell lines LNCaP, DU145, BPH-1 | 4.5–300 μM | DNA SBs ↑ at 9 μM in BPH-1, 37 μM in DU 145, 150 μM in LnCap |
| [ | Epicatechin gallate | Comet assay; MN | C6 astroglial cells | 0.1–1 μM | H2O2-induced DNA SBs and MN formation ↓ |
| [ | Epigallocatechin gallate | γ-H2AX and 8-OH–G by Ab assay | H1299 (human lung adenocarcinoma) cells | 50 μM | γ-H2AX and 8-OH–G ↑ |
| [ | Metabolites of quercetin, chlorogenic acid | Comet assay | LT97 (human colorectal adenoma) cells + cumene hydroperoxide | 2.5 μM/5 μM | Decrease in DNA SBs |
| [ | Epigallocatechin gallate | Comet assay | HeLa (human cervical cancer) cells, p53R (cells with p53 reporter) | 10, 20 μg/mL | DNA SBs ↑ |
| [ | Ethyl gallate | Comet assay | Human carcinoma cell line KB | 20–50 μg/mL | DNA SBs ↑ |
| [ | Tannic acid | Comet assay with Fpg | Human neutrophils | 10–150 μM | DNA SBs ↑ (dose-dependent); weak effect (↑) in TPA-stimulated cells. Fpg sites also ↑, but ↓ in TPA-stimulated cells |
| Resveratrol | DNA damage (SBs) ↑ (dose-dependent); but ↓ (dose-dependent) in TPA-stimulated cells. Same pattern with FPG sites | ||||
| [ | Epigallocatechin gallate; Epicatechin gallate | Comet assay | HEp2 (human laryngeal carcinoma cell line) | 50 μM | With either ECG or EGCG, SBs ↓ at 48 h (from background); no effect at 72 h |
| CK2 (drug resistant, from HEp2) | No effect at 48 or 72 h | ||||
| [ | Curcumin; Ellagic acid | Comet assay | HeLa (human cervical cancer) cells | 25 μM | DNA SBs ↑ (with both together; not significant alone) |
| [ | Curcumin | Chrom abs and PCC | Human lymphocytes, with/without stimulation | 0.14–7 μM | Radioprotective effects seen for both reagents in PCC assay (non-cycling cells) |
| Resveratrol | 2.2–220 μM | ||||
| [ | Curcumin | 8-OH–G by Ab assay | Smooth muscle cells | up to 10 μM | 8-OH–G ↑ |
| [ | Quercetin; Curcumin | γ-H2AX by Ab assay | HT1080 human fibrosarcoma cell line | 30 and 80 μM Quercetin; 10 and 15 μM Curcumin, | Significant increases in γ H2AX |
| MN | 30 μM Quercetin; 10 μM Curcumin | Significant increases in MN. (Quercetin less effective.) | |||
| [ | Soy isoflavones | γ-H2AX by Ab assay | LNCaP (human prostate cancer) cells | 10 μg/mL | No effect on H2AX |
| Curcumin | 25 μg/mL | γ-H2AX ↑ | |||
| [ | Polyphenols | Comet assay | Lymphocytes + B(a)P | 5 μg/mL | DNA SBs ↓ |
| Curcumin | 5 and 10 μg/mL | DNA SBs ↓ | |||
| [ | Curcumin | Comet assay | HCT-116 (human colon cancer) cells | 50 μM | DNA SBs ↑ |
| [ | Curcumin | Comet assay | K562 (human leukaemia) cells | 12.5–200 μM | DNA SBs ↑ |
| [ | Resveratrol | Chrom abs | Human lymphocytes + aflatoxin | 10–100 μM | No effect of resveratrol alone. Dose-dependent decrease in aflatoxin-induced chrom abs |
| [ | Resveratrol | MN; Comet assay | Human bronchial epithelial cell line HBE + Na arsenite | 5 μM | ↓ DNA SBs and MN induced by arsenite |
| [ | Resveratrol | γ -H2AX by Ab assay | HCT-116 (human colon cancer) cells | 25 μM | γ-H2AX foci ↑: DNA damage due to toposiomerase II poisoning |
| [ | Resveratrol | γ -H2AX by Ab assay | Prostate epithelial cells | 5 μM | Ionising radiation-induced damage enhanced |
| [ | Resveratrol | Comet assay | Rat astrocytes + ethanol | 1–10 μM | ↓ DNA SBs induced by ethanol |
| [ | Thymol | Comet assay 24 h after UV | NCTC (human keratinocytes) + UV(A) or UV(B) | 1 μg/mL | DNA SBs ↓ |
| MN | No effect seen | ||||
| γ-H2AX by Ab assay | No effect seen | ||||
| [ | Naringin | Chromosome aberrations | Human lymphocytes treated with Cd | 1, 2 μg/mL | Cd-induced chrom abs ↓ |
| SCE | No significant effect on SCE | ||||
| [ | Rutin | Comet assay | Rat hepatic cell line HTC | 10–810 μg/mL (24 h) | SBs at highest concentration |
| MN | No significant increase in MN—but protection against MN induced by B(a)P | ||||
| [ | Quercetin; Rutin | ã-H2AX by Ab assay | V79 lung fibroblast hamster cells | 100 μg/mL for 12 h | Massive foci, results of lethality |
| [ | Kaempferol | Comet assay | HL-60 human leukemia cells | 75 μM, 6–48 h | SBs induced |
| [ | Quercetin | Comet assay | Lymphocytes from healthy subjects and colon cancer patients, + food mutagens PhIP and IQ | 100, 250, 500 μM | SBs induced by PhIP or IQ ↓ |
| Rutin | 50, 250, 500 μM | ||||
| [ | Fisetin, Kaempferol; Galangin; Quercetin; Luteolin; Chrysin; 7-hydroxyflavone; 7,8-dihydroxyflavone; Baicalein; Rutin | Comet assay; MN | HepG2 (human liver carcinoma) cells + B(a)P | 2.5–25 μM | SBs induced by B(a)P ↓ (all except rutin); MN induced by B(a)P ↓ (all except rutin); Fi>Qu>Ga>Ka>Lu (more effective group); Ch, 7Fl, 7,8Fl, Ba (less effective group) |
| [ | Fisetin | Comet assay | Human hepatic Huh-7 cells | 60 μM | SBs ↑ |
| [ | Kaempferol | Comet assay | Human osteosarcoma cells U2-OS | 50, 100, 150 μM | SBs ↑ (not quantitated) |
| [ | Myricitrin | MN | TK6 (human lymphoblastoid) cells | 20–500 μg/mL for 24 h | MN ↑ (Dose-dependent) |
| Myricetin | 2.5–75 μg/mL for 24 h | MN ↑ (significant?) | |||
| [ | Quercetin and rutin | Comet assay | Human hepatoma cell line HepG2 | 0.1, 1 and 5 μg/mL (2 h of treatment) | No induction of SBs (quercetin and rutin alone) |
| HepG2 + Aflatoxin B, MMS, Dox | Pre-, co- and post-treatment | DNA damage induced by AFB1, MMS, Dox ↓ in all treatment conditions | |||
| [ | Quercetin | Comet assay, 8-OH–G (HPLC) | Human hepatoma cell line HepG2 cells | 0.1, 1 and 5 μg/mL (24 h of treatment) | No effect |
| HepG2 cells + HgCl2 and MeHg | Pre-, co- and post-treatment | DNA damage induced by HgCl2 and MeHg ↓ in pre- and co-treatment | |||
| [ | Quercitrin | Comet assay | Mouse epidermal cell line JB6 + UV(B) | 10, 20 and 80 μM, 30 min | No effect |
| 10, 20 and 80 μM, 30 min + UV(B) | UV(B)-induced SBs ↓ | ||||
| [ | Galangin, chrysin | Comet assay + FPG, EndoIII | AGS human gastric adenocarcinoma cells | 20 μM (1 h) | Base oxidation ↑ |
| [ | Apigenin | Comet assay: Chrom abs; MN | HaCaT human keratinocytes + UV(B) | 15–25 μg/mL | DNA damage ↓, Chrom abs ↓, MN ↓ |
PCB: polychlorinated biphenyls; chrom ab: chromosome aberration; DEN: diethylnitrosamine; Dau: Daunorubicin; TPA: tetradecanoyl phorbol acetate; ECG: epicatechin gallate; EGCG: epigallocatechin gallate; PCC: premature chromosome condensation; SCE: sister chromatid exchange; IQ: 2-amino-3-methylimidazo[4,5-f]quinolone; MMS: methylmethanesulphonate; AFB1: aflatoxin B1.